These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33951331)
1. Paraneoplastic neuromyelitis optica spectrum disorder associated with malignant melanoma: A case report. Morimoto T; Hayashida S; Yamasaki K; Sasahara Y; Takaki T; Yatera K Thorac Cancer; 2021 Jun; 12(11):1775-1779. PubMed ID: 33951331 [TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer. Yuan J; Jia Z; Qin W; Hu W Clin Interv Aging; 2019; 14():1039-1044. PubMed ID: 31239653 [TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation. Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482 [TBL] [Abstract][Full Text] [Related]
4. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer. Kon T; Ueno T; Suzuki C; Nunomura J; Igarashi S; Sato T; Tomiyama M J Neuroimmunol; 2017 Aug; 309():38-40. PubMed ID: 28601284 [TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series. Bernard-Valnet R; Cobo-Calvo A; Siegfried A; Marasescu R; Bonnan M; Ballan G; Ellie E; Bauer J; Uro-Coste E; Marignier R; Brassat D Mult Scler Relat Disord; 2019 Jun; 31():97-100. PubMed ID: 30954932 [TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature. Annus Á; Bencsik K; Obál I; Kincses ZT; Tiszlavicz L; Höftberger R; Vécsei L J Clin Neurosci; 2018 Feb; 48():7-10. PubMed ID: 29133107 [TBL] [Abstract][Full Text] [Related]
7. A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma. Deuel LM; Bunch ME J Neuroimmunol; 2018 Mar; 316():130-132. PubMed ID: 29317098 [TBL] [Abstract][Full Text] [Related]
8. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766 [TBL] [Abstract][Full Text] [Related]
9. A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study. Hirano S; Kojima A; Nakayama Y; Takeda T; Kishimoto T; Takahashi T; Kuwabara S; Mori M BMC Neurol; 2022 Dec; 22(1):483. PubMed ID: 36517738 [TBL] [Abstract][Full Text] [Related]
10. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder subsequent to rhabdomyolysis: a case report and literature review. Shang K; Qin C; Bu BT; Tian DS Int J Neurosci; 2019 Sep; 129(9):930-932. PubMed ID: 30722721 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic Neuromyelitis Optica Spectrum Disorder as Presentation of Esophageal Adenocarcinoma. Wiener DC; Kaplan TB; Bravo-Iñiguez CE; Miller J; Berkowitz AL; Jaklitsch MT Ann Thorac Surg; 2018 Mar; 105(3):e133-e135. PubMed ID: 29455827 [TBL] [Abstract][Full Text] [Related]
13. Overlapping demyelinating syndrome (Neuromyelitis optica spectrum disorders NMOSD with anti-NMDA receptor encephalitis); A case report. Sinani AA; Maawali SA; Alshekaili J; Kindi MA; Ramadhani KA; Khabouri JA; Nadeem A; Salti AA Mult Scler Relat Disord; 2020 Jul; 42():102153. PubMed ID: 32413838 [TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic neuromyelitis optica spectrum disorders: a case series. Virgilio E; Vecchio D; Vercellino M; Naldi P; Tesser F; Cantello R; Cavalla P; Comi C Neurol Sci; 2021 Jun; 42(6):2519-2522. PubMed ID: 33506301 [TBL] [Abstract][Full Text] [Related]
15. Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review. Ran Y; Wang L; Zhang F; Ao R; Dong Z; Yu S Clin Neurol Neurosurg; 2017 Apr; 155():75-82. PubMed ID: 28282627 [TBL] [Abstract][Full Text] [Related]
16. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders. Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer-A case series. Duan Y; Wang X; Duan X; Gao H; Ji X; Xiao X; Zhu F; Xue Q Front Neurol; 2022; 13():1071519. PubMed ID: 36530632 [TBL] [Abstract][Full Text] [Related]
18. [A case of spinal cord infarction accompanied with neuromyelitis optica spectrum pathophysiology]. Katanazaka K; Chihara N; Akazawa S; Ueda T; Sekiguchi K; Matsumoto R Rinsho Shinkeigaku; 2021 Feb; 61(2):127-131. PubMed ID: 33504754 [TBL] [Abstract][Full Text] [Related]
19. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders. Berger B; Hottenrott T; Rauer S; Stich O BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933 [TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]